Institutional Ownership
Kezar Life Sciences Inc
CUSIP 49372L209COM NEW2KZ0Q1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
5.2%
Max % of class reported
Institutional Holders
39
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Feb 13, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bml Capital Management, LLC | 720.8K | $5.35M |
| 2 | Suvretta Capital Management, LLC | 716.8K | $5.32M |
| 3 | Tang Capital Management LLC | 664.3K | $4.93M |
| 4 | Rangeley Capital, LLC | 243.1K | $1.80M |
| 5 | Affinity Asset Advisors, LLC | 229.1K | $1.70M |
| 6 | Renaissance Technologies LLC | 188.4K | $1.40M |
| 7 | Millennium Management LLC | 142.1K | $1.05M |
| 8 | Peapod Lane Capital LLC | 126.7K | $924.5K |
| 9 | Ikarian Capital, LLC | 102.2K | $758.4K |
| 10 | Blackrock, Inc. | 100.1K | $742.5K |